ARCHIVES

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

This article is from The Cancer Letter archive.

Vol. 06 No. 24 | June 13, 1980

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Brown’s appointment may Be Delayed Until After Jan. 20

January 14, 1977

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011